Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Ascertainment of Cancer Cases in the German National Cohort (NAKO): Methods and Initial Results

Verena A Katzke, Volker Arndt, Karin Halina Greiser, Florian Karpa, Dorothee Zoller, Renée Fortner, Karen Steindorf, Michael Hoffmeister, Hermann Brenner, Peter Schirmacher, Michael Leitzmann, Katharina Nimptsch, Ulrike Haug, Katharina Hofmann, Christoph Stallmann, Ulrich Mueller, Andrea Werdecker, Iris Pigeot, Enno Swart, Wolfang AhrensMartin Meyer, Sabine Luttmann, Alice Nennecke, Anne von Rüsten, Joachim Kieschke, Tobias Hartz, Andreas Stang, Wolfgang Hoffmann, Bernd Holleczek, Hans Gert Fabian, Annette Peters, Stefan N Willich, Lilian Krist, Matthias B Schulze, Kathrin Guenther, Hajo Zeeb, Nina Ebert, Börge Schmidt, Anna Köttgen, Alexander Kluttig, Rafael Mikolajczyk, Volker Harth, Nadia Obi, Carolina Klett-Tammen, Manuela Harries, Wolfgang Lieb, Heiko Becher, Heike Minnerup, André Karch, Claudia Meinke-Franze, Hansjörg Baurecht, Ute Mons, Lena Koch-Gallenkamp, Klaus Berger, Henry Völzke, Tobias Pischon, Alexander Katalinic, Rudolf Kaaks

Abstract

BACKGROUND: The German National Cohort (NAKO Gesundheitsstudie) is a prospective cohort study with 205 053 participants. Its goal is to identify risk factors for chronic diseases, including cancer.

METHODS: We describe the methods of ascertaining cancer cases in NAKO (i.e., linkage with cancer registries and self-reporting), the incidence and prevalence figures obtained so far, and the ratios of observed to expected (O/E) case numbers.

RESULTS: Case ascertainment identified 2774 existing cancer cases diagnosed within the five years prior to study enrollment and 4295 new cancer cases diagnosed up to five years after enrollment. Cancers of the breast, prostate, lung, and colorectum made up 55% of the incident cases. Fewer incident cases were found than would have been expected on the basis of incidences in the general population (O/E ratio 0.80, 95% confidence interval [0.76;0.83] for the first two-years of prospective follow-up); the O/E ratio varied across tumor sites (breast 1.02, prostate 1.12, lung 0.38, colorectum 0.62). Possible explanations include healthy volunteer bias, delayed reporting, as well as incomplete data collection from registries and self-reporting.

CONCLUSION: Rising case numbers for the most common types of cancer are expected in the next few years and will enable comprehensive epidemiological analysis of the risk factors of cancer.

OriginalspracheEnglisch
ZeitschriftDeutsches Arzteblatt International
Jahrgang123
Ausgabenummer14
ISSN1866-0452
DOIs
PublikationsstatusElektronische Veröffentlichung vor Drucklegung - 10.07.2026

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Profilbereich: Zentrum für Bevölkerungsmedizin und Versorgungsforschung (ZBV)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Ascertainment of Cancer Cases in the German National Cohort (NAKO): Methods and Initial Results“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren